Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study.

Utku AkgorDerman BasaranMehmet Mutlu MeydanlıEsra KuscuFuat DemirkiranSamet TopuzMuzaffer SancıOzgur AkbayırMurat GultekinMehmet Yavuz SalihogluHüseyin AkıllıTugan BeseZeliha FıratHamdullah SozenNejat OzgulAli Ayhan

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)

Patients with stage IIB endometrial cancer with myometrial invasion ≥50% were more likely to have locoregional and distant metastases. Adjuvant radiotherapy or chemoradiotherapy did not demonstrate an overall survival benefit in these patients.

Keyphrases

endometrial cancer
early stage
risk factors
end stage renal disease
ejection fraction
locally advanced
chronic kidney disease
newly diagnosed
prognostic factors
rectal cancer
lymph node
radiation therapy
peritoneal dialysis
squamous cell carcinoma
patient reported outcomes
patient reported